WATERTOWN, Mass. (AP) _ Kala Pharmaceuticals Inc. (KALA) on Tuesday reported a loss of $47.6 million in its fourth quarter.The Watertown, Massachusetts-based company said it had a loss of 68 cents per share.The biopharmaceutical company posted revenue of $1.9 million in the period, which did not meet Street forecasts. Six analysts surveyed by Zacks expected $3.4 million.For the year, the company reported that its loss widened to $142.6 million, or $2.19 per share. Revenue was reported as $11.2 million._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KALA at https://www.zacks.com/ap/KALA